Page last updated: 2024-10-30

losartan and Hyperprolactinaemia

losartan has been researched along with Hyperprolactinaemia in 1 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pawlikowski, M1
Mucha, S1
Kunert-Radek, J1
Sepien, H1
Pisarek, H1
Stawowy, A1

Other Studies

1 other study available for losartan and Hyperprolactinaemia

ArticleYear
Is estrogen-induced pituitary hyperplasia and hyperprolactinaemia mediated by angiotensin II?
    Advances in experimental medicine and biology, 1995, Volume: 377

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl

1995